Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Lucid Diagnostics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 2.30M | 1.92M | −388.3K (−16.9%) |
| Value | $3.52M | $2.60M | −$919.0K (−26.1%) |
New holders (4)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Levin Capital Strategies, L.P. | 36,799 | $50.0K | 0.01% |
| Arcus Capital Partners, LLC | 3,100 | $4.22K | 0.00% |
| Belpointe Asset Management LLC | 1,500 | $2.04K | 0.00% |
| Bank of America Corp | 18 | $24 | 0.00% |
Sold out (4)
Institutions that held Lucid Diagnostics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 264,653 | $405.0K |
| Citadel Advisors LLC | 35,333 | $54.0K |
| Jane Street Group, LLC | 15,602 | $24.0K |
| BNP Paribas Arbitrage, SA | 973 | $1.49K |